Washington, DC - The U.S. Food and Drug Administration approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with systemic sclerosis or scleroderma, called SSc-ILD. It is the first FDA-approved treatment for this rare lung condition.

Washington, DC - The U.S. continues to experience cases and outbreaks of measles, largely due to unvaccinated or under-vaccinated segments of the population. Measles can be a serious disease. This year has seen the greatest number of measles cases reported in the U.S. since 1992, and since measles was declared eliminated in 2000. Of those diagnosed with measles, approximately 10% have required hospitalization. The majority of cases are among people who were not vaccinated.

Washington, DC - Press Briefing by CBP Acting Commissioner Mark Morgan:

Washington, DC - Seventeen Nominations and Two Withdrawals Sent to the Senate:

Washington, DC - ONDCP Director Jim Carroll at “Turning the Tide – Improving Access to Addiction Care and Overcoming Obstacles to Parity” Event:

Washington, DC - Remarks by President Trump at Presentation of Medals of Valor and Heroic Commendations: